ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1229	46	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
891	after market up a bit BUT news release was at 10PM EST and aftermarket closes at	urslor	3	February 27
890		jargonweary	-	February 27
889	I would assume this is really good news but until we get some f'ing transpar	sukit	3	February 27
888	Here is GROK3's summary and discussion of the significance of today's PR	End2War	2	February 27
887	ir.immunitybio.com [graphic]	CCS648	1	February 27
886	True, not yet money in the door but markets — imperfect though they are at times	jargonweary	5	February 20
885	It's not yet money in the door and what the PR did for me was highlight the	waitwatchwander	-	February 20
884	Market seems unimpressed…at least initially. Perhaps there is an expectation of	jargonweary	1	February 20
883	Would love to know the difference between rBCG and regular BCG when used with An	Redman1234	-	February 20
882	BCG by itself is not a big revenue driver, but the new better recombinant combin	Redman1234	-	February 20
881	The 2 BLA’s will make SP explode, and their closer then they appear in the mirro	Redman1234	-	February 19
880	Recombinant BCG and UK approvals way ahead of schedule. PSS is playing chess not	Redman1234	-	February 19
879	This BCG news is a big deal! Academic centers don't have issues getting BCG,	TinfoilHat	4	February 19
878	Now let's get Anktiva approved in Europe, and then a [global?] licensing dea	Fitzhughlaw	5	February 19
877	manipulation is frustrating ..hope shorts get caught one day...PS thank you IMMU	urslor	2	February 19
876	Next-generation recombinant Bacillus Calmette-Gurin has undergone Phase 2 clinic	zagnut1	3	February 19
875	Troculeucel (SNK01) and M-ceNK are both types of activated autologous NK cells.	Huggenberg	3	February 18
874	On the scientific front, a micro-cap NK player just got Fast Track Designation f	TinfoilHat	5	February 17
873	CULVER CITY, Calif.--(BUSINESS WIRE)--Feb. 13, 2025-- ImmunityBio, Inc. ( NASDAQ	zagnut1	2	February 14
872	For sure next week.	TripleE3	-	February 14
871	He certainly keeps trying .......... From this morning: D. Boral Capital Maint	luckydog88	1	February 14
870	sec.gov	mannamal	-	February 13
869	PSS seems convinced he understands Anktiva's MOA. I like this ending: "	End2War	2	February 10
868	Investing.com SAN DIEGO, CA – Immunity Bio, Inc., a biotechnology firm speciali	bgscolt	4	February 8
867	urologytimes.com Anktiva as a lymphocyte rescue molecule: Unlocking the power of	CCS648	6	February 6

Go to reply# or date (mm/dd/yy):